ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
With EpiPen competitors bearing down, can Mylan maintain its lead?
September 20, 2018The emergency epinephrine market is about to be flush with options. At least three new epinephrine marketers are challenging Mylan’s EpiPen, the longtime market leader still reeling after a price-hike debacle in 2016 and ... -
US FDA approves Mylan’s copy of Allergan’s vaginal cream
January 03, 2018Vaginal atrophy results in thinning and inflammation of the vaginal walls due to less estrogen -
Mylan-Biocon’s breast cancer biosimilar gets ANVISA nod
January 02, 2018Biocon and Mylan’s proposed biosimilar trastuzumab has been approved by Brazilian regulatory agency ANVISA, through their partner Libbs Farmaceutica (Libbs).
Pharma Sources Insight January 2025
